MedAssets (MDAS) Tops Q2 EPS by 4c; Guides FY15 EPS Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
- Qualcomm shares fall on Intel warning and legal concerns
- Marvell Technology shares drop on Lumentum deal concerns
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Oracle shares drop on AI spending concerns and Microsoft criticism
- SpaceX stock drops on launch setback and sector selloff
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
KeyBanc Downgrades MedAssets (MDAS) to Sector Weight
July 31, 2015 7:29 AM EDTKeyBanc downgraded MedAssets (NASDAQ: MDAS) from Overweight to Sector Weight.
Analyst Donald Hooker said, "We are downgrading MedAssets, Inc. (MDAS) to Sector Weight on the recent share price increase (last 6 months: up 26% vs. S&P up 5%). We think the shares are getting a healthy... More
Leerink Raises Price Target on MedAssets (MDAS) Following 2Q EPS Beat
July 30, 2015 10:32 AM EDTLeerink Partners reiterated a Market Perform rating on MedAssets (NASDAQ: MDAS), and raised the price target to $22.00 (from $21.00), following 2Q15 results. MDAS reported 2Q total revenue of $190.4M, ahead consensus of $187.3M. Adjusted EPS of $0.31 was also ahead of consensus of $0.27.
Analyst David Larsen commented, "This afternoon... More



